These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8147183)

  • 1. [What advantages does treatment with highly purified FSH have in infertility?].
    Breckwoldt M; Nieschlag E; Runnebaum B; Schneider HP
    Zentralbl Gynakol; 1994; 116(1):56-7. PubMed ID: 8147183
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twin pregnancy using recombinant gonadotropins in a woman with hypogonadotropic hypogonadism.
    Campo S; Campo V; Lanzone A
    Gynecol Endocrinol; 2002 Feb; 16(1):27-32. PubMed ID: 11915578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women.
    White DM; Polson DW; Kiddy D; Sagle P; Watson H; Gilling-Smith C; Hamilton-Fairley D; Franks S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3821-4. PubMed ID: 8923819
    [No Abstract]   [Full Text] [Related]  

  • 5. [Assisted reproduction strategy on polycystic ovarian syndrome].
    Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):484-6. PubMed ID: 14627036
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of ovarian reserve by using the follicle-stimulating hormone isoform distribution pattern to predict the outcome of in vitro fertilization.
    Letterie GS; Lee JS; Padmanabhan V
    Fertil Steril; 2006 Nov; 86(5):1547-9. PubMed ID: 16999956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.
    Elnashar A; Fouad H; Eldosoky M; Saeid N
    Fertil Steril; 2006 Feb; 85(2):511-3. PubMed ID: 16595244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
    Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
    Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From theory to clinical practice: recombinant FSH in daily practice].
    Kably Ambe A; Barrón Vallejo J; Góngora Rodríguez A; Carballo Mondragón E; Anta Jaén E
    Ginecol Obstet Mex; 1999 Aug; 67():408-13. PubMed ID: 10504796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone.
    Matthews CH; Borgato S; Beck-Peccoz P; Adams M; Tone Y; Gambino G; Casagrande S; Tedeschini G; Benedetti A; Chatterjee VK
    Nat Genet; 1993 Sep; 5(1):83-6. PubMed ID: 8220432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
    Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of concentration of circulating luteinizing hormone in late-follicle phase on the outcome of in vitro fertilization for normogonadotrophic women].
    Sun H; Hu Y; Wang B; Chen Q; Zhang N; Chen H; Wang J; Xu Z
    Zhonghua Nan Ke Xue; 2004 Dec; 10(12):912-5. PubMed ID: 15638021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of pure follicle stimulating hormone during the luteal phase to increase success of ovulation induction in poor responders: a pilot study.
    Trott EA; Chakraborty S; Russell JB
    Del Med J; 1998 May; 70(5):249-51. PubMed ID: 9635346
    [No Abstract]   [Full Text] [Related]  

  • 16. Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2).
    Eijkemans MJ; Polinder S; Mulders AG; Laven JS; Habbema JD; Fauser BC
    Hum Reprod; 2005 Oct; 20(10):2830-7. PubMed ID: 16006473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
    Chen W; Zhang Y; Dai Q
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
    Antoine JM; Loumaye E; Alvarez S; Merviel P; Cornet D; Mandelbaum J; Salat-Baroux J
    Contracept Fertil Sex; 1997 Feb; 25(2):141-6. PubMed ID: 9116774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study.
    Ferrari B; Barusi L; Coppola F
    J Reprod Med; 2002 Feb; 47(2):137-43. PubMed ID: 11883353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.